CE certification for med·wave®

Neuranix is proud to announce to have obtained the CE certification for med·wave® as a class IIa medical device in accordance with Regulation 745/2017 (MDR-Medical Devices Regulation).

Achieving this objective places Neuranix among the first companies in Europe to pass this new certification process featuring stricter clinical trials and deeper process evaluation.

Certification demonstrates the company’s hard work, dedication, and focus on quality.

Obtaining the CE certificate confirms that the device meets all requirements and that the company’s design and manufacturing processes – including regulatory documentation – is compliant to the highest quality standards!

A big thank you to those who have contributed to get where we are today .

Informazioni societarie

Capitale sociale 18.813,99 € non I.V.

Company Info

Social capital 18.813,99 € not I.V.